(888) 645-1617
Drugwatch.com Author

Michelle Llamas Senior Content Writer

Listen to Michelle's podcast on Drugwatch Radio

Check it out
Michelle Y. Llamas strives to empower patients to take charge of their healthcare and be informed consumers. While writing for Drugwatch, she has had the honor of meeting and speaking with people whose lives changed forever because of the negligence of drug and device companies. The relationships she built with these people and their families drive her. She was even able to speak with renowned advocate Erin Brockovich who shared one of her pieces on her website.

Online and print publications have published her work with Drugwatch, including the Journal of Palliative Medicine. She also wrote for the Harvard College Global Health Review and has appeared as a guest on a number of podcasts and radio shows in the U.S and Canada.

Some of the investigative feature stories Michelle has written about include: How the FDA Let Women Down, Selling Side Effects: Big Pharma’s Marketing Machine, Diabetes: Stigma, Blame and Shame, and Misplaced Trust: Why FDA Approval Doesn’t Guarantee Drug Safety.

After she attended the University of Florida, she then spent several years as a legal assistant for Bogin, Munns & Munns—a large plaintiff's law firm in Orlando. It was here that she developed a desire to be an advocate for consumers and a deep respect for the legal system, whose job it is to protect them. She saw that sometimes the only recourse against powerful companies and negligence is the justice system.

But Michelle's ultimate goal was to be able to make a difference with her writing.

So, she decided to attend the technical writing program at the University of Central Florida (UCF). Here, she took complex information and distilled it into a form that was accessible and helpful to the reader. During her last semester, she interned at the UCF Office of Diversity Initiatives.

Her natural desire to advocate and help others led her to develop materials that would help teachers combat bullying in schools. She represented UCF in the first ever Anti-Bullying Summit at the The Holocaust Memorial Resource and Education Center of Central Florida.

When she joined the Drugwatch team in 2012, Michelle realized her goal of combining two of her passions: writing and advocacy. Each day she comes to work knowing that her talents are being used to educate and help people make a difference.


Defective Medical Devices 6.20.17 woman looking at a file

Morcellator Cancer Reports Drop, Essure Reports Rise

Adverse events data collected from the U.S. Food and Drug Administration shows that reports of cancer linked to power...

Learn More
Dangerous Prescription Drugs 6.01.17 doctor with syringe is taking blood for test

Low T Trial: Testosterone Gel Increases Plaque in Arteries

A clinical trial of men with low testosterone (Low T) showed those who used...

Learn More
Dangerous Prescription Drugs 5.19.17

Invokana Gets FDA Black Box Warning for Amputation

The U.S. Food and Drug Administration added a black box warning to the label of Type 2 diabetes medication Invokana...

Learn More
Current Litigation & Lawsuit News 4.25.17 man taking oath in court

J&J, Bayer Accused of Hiding Xarelto Dangers in First Trial

The first Xarelto bellwether trial began on April 24, 2017 in New Orleans, and the plaintiff accused Johnson...

Learn More
Current Litigation & Lawsuit News 4.19.17 gavel over prescription and stethoscope

J&J Faces 3,000 More Risperdal Gynecomastia Lawsuits

An additional 3,000 plaintiffs filed Risperdal (risperidone) gynecomastia lawsuits against Johnson...

Learn More
Current Litigation & Lawsuit News 4.05.17 justice scales & gavel in front of Canadian flag

Canadians Join Hernia Mesh Class Action Lawsuit

As Americans continue to file hernia mesh lawsuits, Canadians began...

Learn More